Drug information, misinformation, and disinformation on social media: a content analysis study

Journal of Public Health Policy

Volumn 39, Issue 3, 2018, Pages 343-357

  Al Khaja, Khalid A J ^a   AlKhaja, Alwaleed K ^b   Sequeira, Reginald P ^a  

^a ARABIAN GULF UNIVERSITY   (Bahrain)

^b QATAR FOUNDATION   (Qatar)

Author keywords

Bahrain; Drug related claims; Evidence base; Independent third party misinformation; Public; Social media; User generated content

Indexed keywords

DRUG;

BAHRAIN; CONSUMER HEALTH INFORMATION; DECEPTION; HUMAN; INFORMATION DISSEMINATION; SOCIAL MEDIA; STATISTICS AND NUMERICAL DATA;

BAHRAIN; CONSUMER HEALTH INFORMATION; DECEPTION; HUMANS; INFORMATION DISSEMINATION; PHARMACEUTICAL PREPARATIONS; SOCIAL MEDIA;

EID: 85047304648     PISSN: 01975897     EISSN: 1745655X     Source Type: Journal    
DOI: 10.1057/s41271-018-0131-2     Document Type: Article

References (34)

1. Kaplan AM, Haenlein M. Users of the world, unite! The challenges and opportunities of social media. Bus Horiz. 2010;53:59–68
2. Kaplan AM, Haenlein M. Social media: back to the roots and back to the future. J Systems Inform. 2012;14:101–4
3. von Muhlen M, Ohno-Machado L. Reviewing social media use by clinicians. J Am Med Inform Assoc. 2012. 10.1136/amiajnl-2012-000990
4. Ventola CL. Social media and health care professionals: benefits, risks, and best practices. Pharm Ther. 2014;39(7):491–520
5. Househ M. The use of social media in healthcare: organizational, clinical, and patient perspectives. In: Courtney KL, et al., editors. Enabling health and healthcare through ICT. Clifton: IOS Press; 2013
6. Dumas A-A, Lapointe A, Desroches S. Users, uses, and effects of social media in dietetic practice: scoping review of the quantitative and qualitative evidence. J Med Internet Res. 2018;20:e55
7. Moorhead SA, Hazlett DE, Harrison L, Carroll JK, Irwin A, Hoving C. A new dimension of health care: systematic review of the uses, benefits, and limitations of social media for health communication. J Med Internet Res. 2013. 10.2196/jmir.1933
8. De Martino I, D’Apolito R, McLawhorn AS, Fehring KA, Sculco PK, Gasparini G. Social media for patients: benefits and drawbacks. Curr Rev Musculoskelet Med. 2017. 10.1007/s12178-017-9394-7
9. Guidance for Industry. Internet/social media platforms: correcting independent third-party misinformation about prescription drugs and medical devices. https://www.fda.gov/downloads/drugs/guidances/ucm401079.pdf. Accessed 14 March 2018
10. Gutierrez MA, Moreno RA, Rebelo MS. Information and communication technologies and global health challenges global health informatics. In: Marin H, Massad E, Gutierrez MA, Rodrigues RJ, Sigulem D, editors. How information technology can change our lives in a globalized world. London: Academic Press; 2017. p. 77–83
11. Bouhnik D, Deshen M. WhatsApp goes to school: mobile instant messaging between teachers and students. JITE Res. 2014;13:217–31
12. Preston I. The tangled web they weave: truth, falsity, & advertisers. Madison: The University of Wisconsin Press; 1994
13. Faerber AE, Kreling DH. Content analysis of false and misleading claims in television advertising for prescription and nonprescription drugs. J Gen Intern Med. 2014. 10.1007/s11606-013-2604-0
14. EMA’s Pharmacovigilance Risk Assessment Committee (PRAC). PRAC concludes that diabetes medicine canagliflozin may contribute to risk of toe amputation. EMA/76661/201. http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/SGLT2_inhibitors_Canagliflozin_20/Recommendation_provided_by_Pharmacovigilance_Risk_Assessment_Committee/WC500221431.pdf (2017). Accessed 15 Oct 2017
15. WHO. Guidelines for the screening, care and treatment of persons with hepatitis C infection. http://apps.who.int/iris/bitstream/10665/111747/1/9789241548755_eng.pdf (2014). Accessed 12 Oct 2017
16. U.S. Food and Drug Administration Graviola Group. https://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm398457.htm (2014). Accessed 15 Oct 2017
17. U.S. Food and Drug Administration. Qualified Health Claims: Letter of Enforcement Discretion - Chromium Picolinate and Insulin Resistance (Docket No. 2004Q-0144). https://wayback.archive-it.org/7993/20171114183739, https://www.fda.gov/Food/IngredientsPackagingLabeling/LabelingNutrition/ucm073017.htm. Accessed 19 March 2018
18. U.S. Food and Drug Administration. FDA approved l-glutamine powder for the treatment of sickle cell disease. https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm566097.htm. Accessed 19 March 2018
19. Myths and Realities - Facts about BPA. https://www.factsaboutbpa.org/bpa-overview/myths-realities. Accessed 19 March 2018
20. Centers for Disease Control and Prevention. CDC 24/7: saving lives. Protecting people. National Biomonitoring Program. Bisphenol A (BPA). https://www.cdc.gov/. Accessed 19 March 2018
21. Hormann AM, Vom Saal FS, Nagel SC, Stahlhut RW, Moyer CL, Ellersieck MR, et al. Holding thermal receipt paper and eating food after using hand sanitizer results in high serum bioactive and urine total levels of bisphenol-A (BPA). PLoS ONE. 2014;9(10):e110509. 10.1371/journal.pone.0110509
22. Losee RM. A discipline independent definition of information. J Am Soc Inf Sci. https://ils.unc.edu/~losee/b5/book5.html (1997). Accessed 19 March 2018
23. Zhou L. Automating linguistics-based cues for detecting deception in text-based synchronous computer-mediated communication. Group Decis Negot. 2004;13:81–106
24. Buckland M. Information as thing. J Am Soc Inf Sci. http://people.ischool.berkeley.edu/~buckland/thing.html (1991). Accessed 19 March 2018
25. Garner SD. High-level colloquium on information literacy and lifelong learning. https://www.ifla.org/publications/high-level-colloquium-on-information-literacy-and-lifelong-learning (2005). Accessed 19 March 2018
26. Karlova NA, Fisher KE. A social diffusion model of misinformation and disinformation for understanding human information behaviour. http://www.informationr.net/ir/18-1/paper573.html#.WhPSUdKWZ0w (2013). Accessed 18 March 2018
27. Aikin KJ, Southwell BG, Paquin RS, Rupert DJ, O’Donoghue AC, Betts KR, et al. Correction of misleading information in prescription drug television advertising: the roles of advertisement similarity and time delay. Res Soc Admin Pharm. 2017. 10.1016/j.sapharm.2016.04.004
28. O’Donoghue AC, Williams PA, Sullivan HW, Boudewyns V, Squire C, Willoughby JF. Effects of comparative claims in prescription drug direct-to-consumer advertising on consumer perceptions and recall. Soc Sci Med. 2014. 10.1016/j.socscimed.2014.08.039
29. Australian Competition & Consumer Commission (ACCC). Full federal court orders $6 million penalty for Nurofen specific pain products. https://www.accc.gov.au/media-release/full-federal-court-orders-6-million-penalty-for-nurofen-specific-pain-products (2016). Accessed 19 March 2018
30. Xiao Q, Bertino E. Detecting deceptive engagement in social media by temporal pattern analysis of user behaviors: a survey. Wiley Interdiscip Rev Data Min Knowl Discov. 2017;7(5):e1210
31. Ahmed H, Traore I, Saad S. Detection of online fake news using N-gram analysis and machine learning techniques. LNCS. Cham: Springer; 2017. p. 127–38
32. Fake News Challenge [Internet]. Fakenewschallenge.org. http://www.fakenewschallenge.org/ (2018). Accessed 19 March 2018
33. Guidance for Industry. Medical Product Communications that are consistent with the FDA-required-labeling-questions and answers. https://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm537130.pdf. Accessed 19 March, 2018
34. Karapanos E, Teixeira P, Gouveia R. Need fulfillment and experiences on social media: A case on Facebook and WhatsApp. Comput Human Behav. 2016;55:888–97